Krystal Biotech buy The Goldman Sachs Group, Inc.
Start price
20.11.23
/
50%
€96.00
Target price
20.11.24
€146.38
Performance (%)
76.41%
End price
21.11.24
€169.35
Summary
This prediction ended on 21.11.24 with a price of €169.35. The BUY prediction by The_Goldman_Sachs_Gr for Krystal Biotech saw massive gains of 76.41%. The_Goldman_Sachs_Gr has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | 5.520% | 5.520% | 61.496% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $160.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten